Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJ C SHAH

Allopathic & Osteopathic Physicians Family Medicine Geriatric Medicine

NPI
1053440503
CMS profile
92766
Location
CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$1,019.05

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Honoraria $880.00 1
Food and Beverage $139.05 3

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Lundbeck LLC $880.00 1
Stryker Corporation $120.09 1
Electromed, Inc. $18.96 2

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJ C SHAH

NPI 1053440503 · CMS profile ID 92766

Allopathic & Osteopathic Physicians / Family Medicine / Geriatric Medicine

CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053440503?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJ C SHAH, NPI 1053440503, CMS profile ID 92766. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053440503?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). RAJ C SHAH, NPI 1053440503, CMS profile ID 92766. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053440503?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
RAJ C SHAH, NPI 1053440503, CMS profile ID 92766, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1053440503?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $1,019.05 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Electromed, Inc. $15.4909/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224606185 CMS
Electromed, Inc. $3.4709/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224606191 CMS
Lundbeck LLC $880.0008/18/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1251846375 CMS
Stryker Corporation $120.0906/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227905426 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $67.68 2
PY2023 $362.10 3
PY2024 $286.48 2
PY2025 $1,019.05 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $5,701.20 5
PY2023 Principal investigator $166,342.96 20
PY2022 Principal investigator $454,172.73 48
PY2021 Principal investigator $501,964.34 72
PY2020 Principal investigator $499,828.82 52
PY2019 Principal investigator $212,426.78 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

72 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $31.13 12/31/2021 Non-covered Recipient Entity
RUSH UNIVERSITY MEDICAL CENTER ALZHEIMERS DISEASE CENTER
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. No dispute reported 06/30/2026 848765387
Principal investigator 1 Janssen Research & Development, LLC $11,365.00 12/28/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594083
Principal investigator 1 Genentech, Inc. $16,585.00 12/24/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835925037
Principal investigator 1 Genentech, Inc. $0.02 12/14/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924861
Principal investigator 1 Genentech, Inc. $2,666.48 12/08/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924855
Principal investigator 1 Janssen Research & Development, LLC $2,242.00 12/08/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594073
Principal investigator 1 Genentech, Inc. $5,108.75 12/01/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924843
Principal investigator 1 Genentech, Inc. $975.00 12/01/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924849
Principal investigator 1 Janssen Research & Development, LLC $276.00 11/17/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594065
Principal investigator 1 Genentech, Inc. $1,333.24 11/16/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924837
Principal investigator 1 Genentech, Inc. $2,802.00 11/15/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835925019
Principal investigator 1 Genentech, Inc. $975.00 11/15/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835925025
Principal investigator 1 Genentech, Inc. $5,850.00 10/20/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835925007
Principal investigator 1 Janssen Research & Development, LLC $508.00 10/20/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594093
Principal investigator 1 Genentech, Inc. $975.00 10/18/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924825
Principal investigator 1 Genentech, Inc. $975.00 10/18/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924831
Principal investigator 1 Genentech, Inc. $1,300.00 10/14/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924819
Principal investigator 1 Genentech, Inc. $5,116.76 10/13/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924813
Principal investigator 1 Janssen Research & Development, LLC $1,950.00 09/24/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594047
Principal investigator 1 Janssen Research & Development, LLC $3,126.00 09/22/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594039
Principal investigator 1 Genentech, Inc. $2,621.70 09/20/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924801
Principal investigator 1 Genentech, Inc. $4,550.00 09/20/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924807
Principal investigator 1 Genentech, Inc. $1,950.00 09/20/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835925001
Principal investigator 1 Genentech, Inc. $2,811.94 09/10/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924795
Principal investigator 1 Genentech, Inc. $13,653.56 09/02/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924789
Principal investigator 1 Genentech, Inc. $3,900.00 08/25/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924995
Principal investigator 1 Janssen Research & Development, LLC $1,158.00 08/25/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594029
Principal investigator 1 Genentech, Inc. $5,850.00 08/20/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924989
Principal investigator 1 Genentech, Inc. $41,849.12 08/12/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924783
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924699
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924705
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924711
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924717
Principal investigator 1 Genentech, Inc. $1,950.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924723
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924730
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924737
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924743
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924749
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924755
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924759
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924766
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924772
Principal investigator 1 Genentech, Inc. $975.00 07/26/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924777
Principal investigator 1 Janssen Research & Development, LLC $6,828.00 07/23/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594055
Principal investigator 1 Genentech, Inc. $975.00 07/21/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924977
Principal investigator 1 Genentech, Inc. $5,631.57 07/01/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924693
Principal investigator 1 Janssen Research & Development, LLC $1,950.00 06/23/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594021
Principal investigator 1 Genentech, Inc. $1,917.00 06/14/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924687
Principal investigator 1 Genentech, Inc. $9,329.00 06/14/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924947
Principal investigator 1 Genentech, Inc. $16,526.73 06/04/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924681
Principal investigator 1 Genentech, Inc. $1,411.00 06/01/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924675
Principal investigator 1 Janssen Research & Development, LLC $21,604.00 05/24/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594011
Principal investigator 1 Genentech, Inc. $1,411.00 05/21/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924663
Principal investigator 1 Genentech, Inc. $1,411.00 05/21/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924669
Principal investigator 1 Genentech, Inc. $5,167.50 05/21/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924941
Principal investigator 1 Genentech, Inc. $5,983.37 05/17/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924657
Principal investigator 1 Genentech, Inc. $8,354.00 05/17/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924935
Principal investigator 1 Genentech, Inc. $3,900.00 04/23/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924923
Principal investigator 1 Janssen Research & Development, LLC $41,910.00 04/23/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787594003
Principal investigator 1 Genentech, Inc. $1,174.16 04/15/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924651
Principal investigator 1 Janssen Research & Development, LLC $44,439.00 03/24/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787593993
Principal investigator 1 Genentech, Inc. $2,925.00 03/18/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924917
Principal investigator 1 Janssen Research & Development, LLC $6,290.00 03/17/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787593985
Principal investigator 1 Janssen Research & Development, LLC $32,855.00 02/22/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787593977
Principal investigator 1 Janssen Research & Development, LLC $49,897.00 02/19/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787593969
Principal investigator 1 Genentech, Inc. $5,127.00 02/17/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924905
Principal investigator 1 Genentech, Inc. $1,971.90 02/16/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924639
Principal investigator 1 Genentech, Inc. $10,388.27 02/16/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924645
Principal investigator 1 Janssen Research & Development, LLC $46,566.00 01/26/2021 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants No dispute reported 06/30/2026 787593959
Principal investigator 1 Genentech, Inc. $5,587.00 01/15/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 835924893
Principal investigator 1 Genentech, Inc. $1,333.24 01/13/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 835924633
Principal investigator 1 Genentech, Inc. $1,971.90 01/12/2021 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 835924627